Delivery Order SPE2DR25D1053-SPE2DR26FT324
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg tablets (28-count package) under a firm fixed-price contract. The award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $15,151.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 280 mg tablets (28 count) on June 6, 2025, with completion targeted for June 30, 2025. This non-competitive, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Imbruvica 140 mg tablets (28-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (quantity 28) on September 24, 2025, with an ultimate completion date of October 16, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Imbruvica 420 mg tablets (28-count units) valued at $53,030.25 with a firm fixed price structure. The order is scheduled for completion by September 9, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded contract and is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,151.50 to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Imbruvica 280 mg tablets (28-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for completion by November 6, 2025, with performance and delivery from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $15,151.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Imbruvica 420 mg tablets (28-count units). The contract, which is a non-set-aside competitive award, is scheduled for completion by October 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 280 mg tablets (28-count units) on September 4, 2025, with completion expected by September 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $22,727.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count package), with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed from the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count) under a firm fixed-price contract on April 21, 2025. The contract carries a ceiling value of $15,151.52 and requires completion by May 12, 2025. This non-set-aside, competitively awarded delivery order represents a continuation of pharmaceutical supply services to support federal medical procurement needs, with performance occurring at...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT324Delivery Order
The Defense Logistics Agency awarded a $15,967.36 delivery order to AmerisourceBergen Drug Corp for 28-tablet containers of Imbruvica 420 mg on October 27, 2025, with completion scheduled for November 18, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive procurement under the company's broader pharmaceutical supply relationship with the federal government. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical support vehicle that extends through December 2026. The IDC enables the contractor to supply a diverse range of pharmaceutical products, brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's established role as a critical pharmaceutical vendor for the Defense Health Agency and other federal healthcare systems demonstrates its capability to fulfill specialized medical procurement requirements, including oncology medications such as Imbruvica, across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 10/27/25 |